MALLINCKRODT
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.
MALLINCKRODT
Social Links:
Industry:
Biotechnology
Founded:
1867-01-01
Address:
Blanchardstown, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.mallinckrodt.com
Total Employee:
5001+
Status:
Active
Contact:
+1 314-654-2000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-12-26 | Sucampo Pharmaceuticals | Sucampo Pharmaceuticals acquired by Mallinckrodt | 1.2 B USD |
| 2017-11-02 | Ocera Therapeutics | Ocera Therapeutics acquired by Mallinckrodt | 42 M USD |
| 2017-08-04 | InfaCare Pharmaceutical | InfaCare Pharmaceutical acquired by Mallinckrodt | N/A |
| 2016-08-10 | Stratatech Corporation | Stratatech Corporation acquired by Mallinckrodt | N/A |
| 2015-08-10 | Therakos | Therakos acquired by Mallinckrodt | 1.33 B USD |
| 2015-03-05 | Ikaria | Ikaria acquired by Mallinckrodt | 2.3 B USD |
| 2014-04-07 | Questcor Pharmaceuticals | Questcor Pharmaceuticals acquired by Mallinckrodt | N/A |
| 2014-02-11 | Cadence Pharmaceuticals | Cadence Pharmaceuticals acquired by Mallinckrodt | N/A |
| 2012-09-24 | CNS Therapeutics (Old) | CNS Therapeutics (Old) acquired by Mallinckrodt | 100 M USD |
| 1997-07-24 | Nellcor Puritan Bennett | Nellcor Puritan Bennett acquired by Mallinckrodt | 1.81 B USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-07-18 | Silence Therapeutics | Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics | 5 M USD |
Newest Events participated
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Official Site Inspections
http://www.mallinckrodt.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.69 K
- Host name: 45.60.250.79
- IP address: 45.60.250.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mallinckrodt"
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical …
As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.See details»
Get to Know Our Specialty Pharmaceutical Company | Mallinckrodt ...
Mallinckrodt Pharmaceuticals - Listening for Needs.
Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty …See details»
Mallinckrodt - Wikipedia
Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. In 2017, it generated 90% of its sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversionSee details»
Integrity and Compliance | Mallinckrodt Pharmaceuticals
Mallinckrodt is committed to maintaining an effective Compliance Program grounded in integrity that follows all applicable laws, regulations, and codes of the countries in which it operates.See details»
Investor Overview | Mallinckrodt
Apr 12, 2024 · Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Listening for Needs. Delivering Solutions. We provide …See details»
Mallinckrodt Pharmaceuticals - LinkedIn
As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology,...See details»
Mallinckrodt Group Inc. -- Company History
The Mallinckrodt Group is organized into two separate companies: Mallinckrodt Medical Inc. and Mallinckrodt Specialty Chemicals Company. A majority of its revenues are from its human …See details»
Mallinckrodt - Crunchbase Company Profile & Funding
Pain relief medications developed and marketed by Mallinckrodt. Gastrointestinal Products: Pharmaceuticals targeting gastrointestinal conditions.See details»
Our Story | Mallinckrodt Pharmaceuticals
Scroll to explore the milestones and achievements that have made Mallinckrodt the leading pharmaceuticals company it is today. Emil Mallinckrodt purchases a plot of land in the Bremen area of St. Louis, Missouri, which becomes the site …See details»
News Detail | Mallinckrodt Pharmaceuticals
Jun 16, 2022 · Supported by existing drug development programs and approximately 2,800 talented employees globally, the Company is poised to build on its 155-year history of …See details»
Science & Technology | Mallinckrodt Pharmaceuticals
Portfolio expansion is a strategic priority for our Science and Technology organization. We are committed to both developing new medicines and generating relevant clinical, health economic …See details»
Mallinckrodt Pharmaceuticals | World Economic Forum
Mallinckrodt's growing portfolio of specialty pharmaceuticals and global medical imaging products has expanded to help treat a wide variety of health conditions, from pain to central nervous …See details»
Mallinckrodt Plan of Reorganization Confirmed by U.S. Court - PR …
Feb 3, 2022 · Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and …See details»
Who We Are | Mallinckrodt Pharmaceuticals
Our teams operate throughout the U.S., Europe, and beyond, working collaboratively to solve complex problems with unmatched skill and unconstrained innovation. Our areas of focus …See details»
Mallinckrodt Recognized as Industry Innovator at National …
May 5, 2023 · Mallinckrodt is being recognized for the U.S. Food and Drug Administration (FDA) approval of TERLIVAZ ® (terlipressin) for injection for the treatment of adults with HRS with …See details»
STRONGER TOGETHER Stronger tomorrow - Mallinckrodt
Mallinckrodt’s strategic vision is to be an innovation-driven biopharmaceutical company focused on improving outcomes for patients with severe and critical conditions.See details»
Mallinckrodt Emerges from Chapter 11 with ... - Markets Insider
Jun 16, 2022 · Supported by existing drug development programs and approximately 2,800 talented employees globally, the Company is poised to build on its 155-year history of …See details»
Mallinckrodt plc Reports Second Quarter 2022 Financial Results …
DUBLIN, Aug. 11, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) (" Mallinckrodt " or the "Company"), a global specialty pharmaceutical company, today reported results for the …See details»
Corporate Social Responsibility (CSR) - Mallinckrodt
From responsible use efforts to community outreach, Mallinckrodt weaves social responsibility into every area its business touches. Learn more on our site.See details»